Accès ouvert

Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

Article scientifique 2021 Anglais

Résumé

Following the publication of the original article [1], we were notified of an error in the affiliation of 3 authors of the article: Celine Roy, Laura Richert and Genevieve Chene. Their affiliation was initially mentioned as: “Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia” However, their correct affiliation is: Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.tp.

Citer ce document

Badio, M., Lhomme, É., Kieh, M., Béavogui, A., Kennedy, S., Doumbia, S., Leigh, B., Sow, S., Diallo, A., Fusco, D., Kirchoff, M., Termote, M., Vatrinet, R., Wentworth, D., Espérou, H., Lane, H., Pierson, J., Watson‐Jones, D., Roy, C., D’Ortenzio, É., Greenwood, B., Chêne, G., Richer, L., Neaton, J., Yazdanpanah, Y. (2021). Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries. https://doi.org/10.1186/s13063-021-05572-3

Accès au document

Voir sur le dépôt source

Ce document est hébergé sur son dépôt institutionnel d'origine.

Statistiques

Consultations : 1

Téléchargements : 0